Prolonged loss of D1 receptor signaling promotes maladaptive plasticity of direct pathway striatal projection neurons
As Parkinson's disease (PD) progresses and nigrostriatal dopamine (DA) neuron degeneration worsens, DA replacement therapies shift from restoring motor function to evoking dyskinesia. How disease progression mediates this transition remains poorly understood. Here, we optimized a 6-hydroxydopamine (6OHDA) model that reliably generates multiple severities of DA axon denervation within the striatum…
We haven't written up this one. bioRxiv has the full story — the link below goes straight to it.